ID: ALA3742035

Max Phase: Preclinical

Molecular Formula: C23H19N

Molecular Weight: 309.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(NC(c2ccccc2)c2ccc3ccccc3c2)cc1

Standard InChI:  InChI=1S/C23H19N/c1-3-10-19(11-4-1)23(24-22-13-5-2-6-14-22)21-16-15-18-9-7-8-12-20(18)17-21/h1-17,23-24H

Standard InChI Key:  WPJYDTYFROQBPI-UHFFFAOYSA-N

Associated Targets(Human)

Prenyl protein specific protease 365 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 309.41Molecular Weight (Monoisotopic): 309.1517AlogP: 6.04#Rotatable Bonds: 4
Polar Surface Area: 12.03Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.60CX LogP: 5.94CX LogD: 5.94
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.48Np Likeness Score: -0.80

References

1. Mohammed I, Hampton SE, Ashall L, Hildebrandt ER, Kutlik RA, Manandhar SP, Floyd BJ, Smith HE, Dozier JK, Distefano MD, Schmidt WK, Dore TM..  (2016)  8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.,  24  (2): [PMID:26706114] [10.1016/j.bmc.2015.11.043]

Source